PT103177A - 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos - Google Patents

1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos

Info

Publication number: PT103177A
Authority: PT; Portugal
Prior art keywords: colecalciferol; epi; homo; diene; medicines
Prior art date: 2003-09-24

Application number

PT103177A

Other languages

English (en)

Inventor

Adorini Luciano

Colli Enrico

Original Assignee

Bioxell Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-24

Filing date

2004-07-29

Publication date

2005-03-31

2003-09-24 Priority claimed from GB0322395A external-priority patent/GB0322395D0/en

2003-11-03 Priority claimed from GB0325598A external-priority patent/GB2407499B/en

2004-07-29 Application filed by Bioxell Spa filed Critical Bioxell Spa

2005-03-31 Publication of PT103177A publication Critical patent/PT103177A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT103177A 2003-09-24 2004-07-29 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos PT103177A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0322395A GB0322395D0 (en)	2003-09-24	2003-09-24	Methods for treating bladder dysfunction and related compounds and compositions
GB0325598A GB2407499B (en)	2003-11-03	2003-11-03	Vitamin D3 analogue for use in the treatment of BPH

Publications (1)

Publication Number	Publication Date
PT103177A true PT103177A (pt)	2005-03-31

Family

ID=34315450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT103177A PT103177A (pt)	2003-09-24	2004-07-29	1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos

Country Status (5)

Country	Link
US (2)	US7332482B2 (pt)
AU (2)	AU2004203436A1 (pt)
CA (1)	CA2476224A1 (pt)
PT (1)	PT103177A (pt)
SG (1)	SG110107A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070034524A (ko) *	2004-05-28	2007-03-28	버텍스 파마슈티칼스 인코포레이티드	무스카린 수용체 조정자
US20060204588A1 (en) *	2005-03-10	2006-09-14	Elan Pharma International Limited	Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
US20100009949A1 (en) *	2006-03-24	2010-01-14	Bioxell S.P.A.	Novel method
WO2008106536A1 (en) *	2007-02-28	2008-09-04	Kissei Pharmaceuticals Co., Ltd.	Use of silodosin in a once daily administration for treating benign prostatic hyperplasia
US8154421B2 (en) *	2009-05-12	2012-04-10	Fisher Clinical Services Inc.	Real time temperature and location tracker
EP2407152A1 (en)	2010-07-15	2012-01-18	Hybrigenics S.A.	Formulations of 14-epi-analogues of vitamin D
JP5836373B2 (ja)	2010-07-15	2015-12-24	ヒブリジェニクス・エスアー	ビタミンｄの１４−エピ−アナログの新しい製剤
US10441561B2 (en)	2012-07-26	2019-10-15	The William M. Yanbrough Foundation	Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
EP3053598A1 (en)	2015-02-06	2016-08-10	Faes Farma, S.A.	Calcifediol soft capsules

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5795882A (en) *	1992-06-22	1998-08-18	Bone Care International, Inc.	Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) *	1993-09-10	1998-06-09	Bone Care International, Inc.	Method of treating prostatic diseases using active vitamin D analogues
US5428029A (en)	1993-11-24	1995-06-27	Hoffmann-La Roche Inc.	Vitamin D3 fluorinated analogs
TW403735B (en) *	1995-11-22	2000-09-01	Hoffmann La Roche	25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
US5747479A (en) *	1996-01-03	1998-05-05	Hoffmann-La Roche Inc.	Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
SG70010A1 (en)	1996-05-23	2000-01-25	Hoffmann La Roche	Fluorinated vitamin d3 analogs
US5939408A (en) *	1996-05-23	1999-08-17	Hoffman-La Roche Inc.	Vitamin D3 analogs
SG70009A1 (en)	1996-05-23	2000-01-25	Hoffmann La Roche	Vitamin d3 analogs
US20020128240A1 (en) *	1996-12-30	2002-09-12	Bone Care International, Inc.	Treatment of hyperproliferative diseases using active vitamin D analogues
US6008209A (en) *	1997-04-28	1999-12-28	Hoffmann-La Roche Inc.	Method of using vitamin D3 analogs with bis C-20 side chains
DK0980354T3 (da)	1997-04-28	2002-10-14	Hoffmann La Roche	Vitamin D3-analoger med bis-C20-sidekæder
US5872113A (en) *	1997-05-16	1999-02-16	Syntex (U.S.A.) Inc.	Fluorinated vitamin D3 analogs
US5811414A (en) *	1997-05-16	1998-09-22	Hoffmann-La Roche Inc.	Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
IT1297381B1 (it)	1997-12-09	1999-09-01	Mario Serio	Uso di analoghi della vitamina d3 come inibitori della proliferazione di cellule ipertrofiche di prostata umana
US5972917A (en)	1998-05-29	1999-10-26	Bone Care Int Inc	1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US6603030B1 (en)	1999-04-22	2003-08-05	Hoffman-La Roche Inc.	Process for producing phosphineoxide vitamin D precursors
US6255501B1 (en)	1999-04-26	2001-07-03	Hoffman-La Roche Inc.	Process for preparing antiosteoporotic agents
US6331642B1 (en) *	1999-07-12	2001-12-18	Hoffmann-La Roche Inc.	Vitamin D3 analogs
AU1153201A (en)	1999-10-25	2001-05-08	Strakan Limited	Uses of 1,25-dihydroxy-5,6-trans vitamin D compounds and derivatives thereof
KR20050032507A (ko)	2001-10-10	2005-04-07	파마시아 이탈리아 에스.피.에이.	스테로이드 화합물을 이용한 골소실의 예방 및 치료 방법
WO2003034961A1 (en)	2001-10-23	2003-05-01	Euro-Celtique, S.A.	Terazosin transdermal device and methods
KR20050044655A (ko)	2001-12-03	2005-05-12	노바세아, 인크.	활성 비타민 ｄ 화합물을 함유하는 약제학적 조성물

2004
- 2004-07-29 PT PT103177A patent/PT103177A/pt not_active IP Right Cessation
- 2004-07-29 AU AU2004203436A patent/AU2004203436A1/en not_active Abandoned
- 2004-07-29 CA CA002476224A patent/CA2476224A1/en not_active Abandoned
- 2004-07-29 US US10/903,211 patent/US7332482B2/en not_active Expired - Fee Related
- 2004-07-29 SG SG200404316A patent/SG110107A1/en unknown
2007
- 2007-10-24 US US11/977,502 patent/US20080207769A1/en not_active Abandoned
2008
- 2008-07-30 AU AU2008203397A patent/AU2008203397A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2476224A1 (en)	2005-03-24
SG110107A1 (en)	2005-04-28
US20080207769A1 (en)	2008-08-28
AU2008203397A1 (en)	2008-08-21
US7332482B2 (en)	2008-02-19
US20050065124A1 (en)	2005-03-24
AU2004203436A1 (en)	2005-04-14

Similar Documents

Publication	Publication Date	Title
CY2018009I1 (el)	2018-06-27	Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
ITRM20020264A0 (it)	2002-05-15	Articolo assorbente e procedimento per la sua fabbricazione.
DE602004000683D1 (de)	2006-05-24	Fingerabdrucksensor und dessen Herstellungsverfahren
NL1025404A1 (nl)	2004-08-09	Pyrazolo-triazine verbindingen en gebruik daarvan.
EP1701750A4 (en)	2011-11-02	CONTROLLABLE ULTRASONIC CATHETER
DE60206490D1 (de)	2005-11-10	Geschirrspülmaschine mit durch den Spülwasserstrom rotierbarer Filter- und Zerkleinerungsvorrichtung
TWI347844B (en)	2011-09-01	Sulfoximine-substituted pyrimidines as cdk-and/or vegf inhibitors, their production and use as pharmaceutical agents
DK1620118T3 (da)	2014-09-29	Reversible pegylerede lægemidler
CY2012025I1 (el)	2015-08-05	Υπο-ακετυλιωμενα και υπερ-ακετυλιωμενα μηνιγγοκοκκικα καψικα σακχαριδια
NO20052855D0 (no)	2005-06-13	Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
BR0300396B1 (pt)	2013-02-19	artigo absorvente higiÊnico.
PT1419150E (pt)	2005-08-31	Derivados de 1-fenilsulfonil-1,3-di-hidro-2h-indol-2-ona, sua preparacao e sua aplicacao em terapeutica
FI20031436L (fi)	2005-04-04	Menetelmä sydämen lyöntien tunnistamiseksi ja siitä saatavien suureiden laskemiseksi
EE200300485A (et)	2004-02-16	Tiohüdantoinid ja nende kasutamine diabeedi raviks
DK1603565T3 (da)	2008-11-10	Medikament omfattende en höjaktiv længevarende beta2-agonisk i kombination med andre aktive ingredienser
EP1513825A4 (en)	2011-01-05	ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
DE60238980D1 (de)	2011-03-03	Verbesserungen in Funkortungsystemen
EE200300311A (et)	2003-10-15	Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
BR0208971B1 (pt)	2011-04-19	produto absorvente com ajuste melhorado.
BR0208969B1 (pt)	2011-04-19	produto absorvente com ajuste melhorado.
PT1513836E (pt)	2006-09-29	Derivados de piperazinilacilpiperidina, sua preparacao e sua aplicacao em terapeutica
DE50213460D1 (de)	2009-05-28	Spirocyclische 3-phenyl-3-substituierte-4-ketolaktame und -laktone
IL163900A (en)	2015-07-30	Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
EP1680521A4 (en)	2007-07-25	PREPARATION OF TITANIUM OXIDE
PT103177A (pt)	2005-03-31	1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos

Legal Events

Date	Code	Title	Description
2005-03-31	BB1A	Laying open of patent application
2011-02-07	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20110131

Date

Code

Title

Description

2005-03-31

BB1A

Laying open of patent application

2011-02-07

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20110131